104 related articles for article (PubMed ID: 8319788)
1. Influence of aspirin on human megakaryocyte prostaglandin synthesis.
van Pampus EC; Huijgens PC; Zevenbergen A; Twaalfhoven H; van Kamp GJ; Langenhuijsen MM
Eur J Haematol; 1993 May; 50(5):264-8. PubMed ID: 8319788
[TBL] [Abstract][Full Text] [Related]
2. Aspirin does not inhibit human megakaryocyte thromboxane synthesis in vivo.
Huijgens PC; van den Berg CA; Imandt LM; Miltenburg A; Langenhuijsen MM
Scand J Haematol; 1986 Jan; 36(1):92-5. PubMed ID: 3081996
[TBL] [Abstract][Full Text] [Related]
3. Aspirin inhibits rat megakaryocyte thromboxane synthesis.
Worthington RE; Nakeff A
Prostaglandins; 1982 Jun; 23(6):841-53. PubMed ID: 6812167
[TBL] [Abstract][Full Text] [Related]
4. Recovery of megakaryocyte thromboxane production in vitro after aspirin inhibition.
Walenga RW; Miller JL; Stuart MJ
Biochem Biophys Res Commun; 1984 Mar; 119(3):982-8. PubMed ID: 6712680
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane synthesis in megakaryocytes isolated by centrifugal elutriation.
Worthington RE; Nakeff A
Blood; 1981 Jul; 58(1):175-8. PubMed ID: 6786393
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
7. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
[TBL] [Abstract][Full Text] [Related]
8. The effects of aspirin on megakaryocyte prostaglandin production.
Demers LM; Budin RE; Shaikh BS
Proc Soc Exp Biol Med; 1980 Jan; 163(1):24-9. PubMed ID: 6766214
[No Abstract] [Full Text] [Related]
9. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture.
Walenga RW; Miller JL; Stuart MJ
Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879
[TBL] [Abstract][Full Text] [Related]
10. Combining counterflow centrifugal elutriation and glycoprotein Ib-dependent purification of human megakaryocytes: efficacy and selectivity.
van Pampus EC; van Geel BJ; Huijgens PC; Wijermans PW; Ossenkoppele GJ; Rodriguez F; Zevenbergen A; Langenhuijsen MM
Eur J Haematol; 1991 Oct; 47(4):299-304. PubMed ID: 1954990
[TBL] [Abstract][Full Text] [Related]
11. Aspirin inhibits platelet 12-hydroxy-eicosatetraenoic acid formation.
Eynard AR; Galli G; Tremoli E; Maderna P; Magni F; Paoletti R
J Lab Clin Med; 1986 Jan; 107(1):73-8. PubMed ID: 3941295
[TBL] [Abstract][Full Text] [Related]
12. In vitro stimulation of megakaryocyte maturation by megakaryocyte stimulatory factor.
Greenberg SM; Kuter DJ; Rosenberg RD
J Biol Chem; 1987 Mar; 262(7):3269-77. PubMed ID: 3546304
[TBL] [Abstract][Full Text] [Related]
13. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R
Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545
[TBL] [Abstract][Full Text] [Related]
14. Recovery of cyclooxygenase activity after aspirin in populations of platelets separated on stractan density gradients.
McDonald JW; Ali M
Prostaglandins Leukot Med; 1983 Nov; 12(3):245-52. PubMed ID: 6419234
[TBL] [Abstract][Full Text] [Related]
15. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
Preston FE; Greaves M; Jackson CA; Stoddard CJ
Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
17. Effect of aspirin on ex vivo generation of thromboxane in healthy horses.
Baxter GM; Moore JN
Am J Vet Res; 1987 Jan; 48(1):13-6. PubMed ID: 3826831
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of platelet cyclooxygenase inhibition.
Patrono C; Ciabattoni G; Patrignani P; Pugliese F; Filabozzi P; Catella F; Davì G; Forni L
Circulation; 1985 Dec; 72(6):1177-84. PubMed ID: 3933848
[TBL] [Abstract][Full Text] [Related]
19. Effect of phorbol myristate acetate on c-myc, beta-actin, and FV gene expression in morphologically recognizable human megakaryocytes: a kinetic analysis employing in situ hybridization.
Gewirtz AM; Shen YM
Exp Hematol; 1990 Sep; 18(8):945-52. PubMed ID: 2201557
[TBL] [Abstract][Full Text] [Related]
20. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
Pedersen AK; FitzGerald GA
N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
